- The global Vitamin K2 Market Share is segmented by product type, source, form, and application.
- By product type, MK-7 accounted for 71.61% market share in 2017, followed by MK-4 (21.87%) and others (6.52%). The MK-7 segment can touch a value of USD 165.91 million by 2023. On the other hand, MK-4 can accrue USD 48.93 million at a CAGR of 30.63% during the forecast period.
- By source, natural accounted for 64.88% share and synthetic accounted for 35.12% share in 2017 respectively. The natural source is expected to exhibit 30.72% CAGR during the forecast period to touch a size of USD 145.73 million by 2023. On the other hand, the synthetic segment is projected to reach USD 82.54 million by 2023, growing at 31.73% CAGR over the assessment period.
- By form, powder held 52.75% share in 2017, followed by oil (36.96%) and others (10.29%). The powder form can accrue revenue worth USD 117.89 million by 2023, exhibiting 30.62% CAGR during the review period. The oil segment can display the strongest CAGR of 32.61% over the assessment period to reach a size of USD 90.43 million by 2023. This can be credited to its effective dosage method for supplying K2 successfully.
- Among applications, nutraceutical & food accounted for 85.46% share in 2017, while pharmaceutical held 14.54% share. The pharmaceutical segment can exhibit 32.05% CAGR during the forecast period to generate USD 34.69 million for the Vitamin K2 Market Share by 2023.
Vitamin K2 Market Share Research Report: by Product Type (MK-7, MK-4, Others), By Source (Natural, Synthetic), By Form (Oil, Powder, Others), By Application (Nutraceutical & Food, Pharmaceutical) and Region - Global Forecast till 2023Market OverviewVitamin K2, also known as menaquinones, are a group of compounds known for preventing cardiovascular diseases and bone diseases.
The vitamin is responsible for ensuring calcium is absorbed by the bone matrix and prevent its deposition in the arteries.The “Vitamin K2 Market Share” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.The Vitamin K2 Market Share Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the major players such As, Kappa Bioscience (Norway), NattoPharma (Norway), Gnosis SpA (Italy), Viridis BioPharma (India), Seebio Biotech (China), DSM (The Netherlands), Danisco A/S (U.S.), Geneferm Biotechnology Co. Ltd. (Taiwan), Frutarom (Israel), and Kyowa Hakko Bio Co. Ltd. (Japan).SegmentationFor the scope of the report, the global Vitamin K2 Market Share is segmented in the following mannerProduct TypeMK-7MK-4OthersSourceNaturalSyntheticFormOilPowderOthersApplicationNutraceutical & FoodPharmaceuticalAccess Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/vitamin-k2-market-7495Reasons to Purchase this ReportQualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factorsProvision of market value (USD Billion) data for each segment and sub-segmentIndicates the region and segment that is expected to witness the fastest growth as well as to dominate the marketAnalysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each regionThe competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiledThe report also appraises the supervisory scenarios which affect various decisions in the market.
With all the data congregated and scrutinized using SWOT analysis, there is a vibrant picture of the competitive scenario of the Global Vitamin K2 Market Share.
Openings for the future market growth were uncovered and preoccupied competitive threats also textured.About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.Contact:Market Research Future+1 646 845 9312Email: [email protected]
The global “Vitamin K2 Market” research report addresses the need for an industry- and economy-wide database beneficial for the business management that could potentially offer development and profitability in the market.
It also draws focus on technologies, volume, materials & markets, and in-depth market analysis of the Vitamin K2 sector.
The study has a section dedicated to profiling the dominant companies in the market while providing their market shares.Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/112The Vitamin K2 market intelligence study includes a separate section dedicated to crucial parameters like the pricing structure of vital feedstock and value chain analysis, along with the study of major suppliers of the raw materials.
It also offers other pivotal information about the Vitamin K2 market as part of a wide-ranging analysis of the supply chain, along with other aspects like prominent distributors and the consumer base.In market segmentation by manufacturers, the report covers the following companies- Kappa Bioscience, NattoPharma, Gnosis, DSM, Viridis BioPharma, Frutarom, DuPont Nutrition & Health, GeneFerm Biotechnology, Shanghai Reson Biotech, Guangdong Goodscend, Seebio Biotech, Kyowa HakkoFurthermore, the research report projects the changes in the supply-demand dynamics, market value, market competition, leading market players, and market estimations from 2019 to 2022.
Click here to know more @ https://www.reportsanddata.com/discount-enquiry-form/112Scope of the Research:The report offers an in-depth assessment of the competitive scenario, taking into consideration the market shares held by leading companies.
It also discusses the supply-demand dynamics and key participants with vital business intelligence and helps them with a research-backed forecast for the global Vitamin K2 market.The evaluation includes the forecast, a summary of the competitive landscape, the market shares of competitors, as well as the market trends, demands, opportunities and challenges existing in the sector, and elaborate product analysis.
Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), Source (Natural, Synthetic), Form (Oil, Powder, Others), Application (Nutraceutical & Food, Pharmaceutical) and Region - Forecast till 2027Overview:Vitamin K2, or menaquinones, is a group of compounds that is known for their ability to check cardiovascular diseases and bone diseases.
The vitamin assists in the absorption of calcium by the bone matrix and arrests its deposition in the arteries.
The global vitamin K2 market is all set to score a valuation of USD 228.27 million by 2023.
This segmentation provides a better insight regarding factors that can trigger change in the market of the coming years.Based on the product type, the global vitamin K2 market can be segmented into MK-4, MK-7, and others.
The MK-4 segment can surpass USD 48.93 million with a 30.63% CAGR during the forecast period.Based on the source, the vitamin K2 market can be segmented into natural and synthetic.
On the other hand, the synthetic segment can cross the estimated valuation of USD 82.54 million by 2023 by taking a speed of around 31.73% CAGR over the review period.Based on the form, the vitamin K2 market can be segmented into oil and powder.
The global Vitamin K2 market size is expected to reach USD 290.3 million by 2026 according to a new study by Polaris Market Research.
The alarming cases of vitamin deficiency in humans are anticipated to be a primary trigger for demand in the global market.
A study conducted by the Food & Agriculture Organization of United Nations (FAO) in the year 2018 revealed that vitamin K deficiency bleeding (VKDB) in infants has emerged to be a major concern for infant mortality.
Production method of the ingredient is a crucial concern particularly in the pharmaceutical industry, as manufacturers have to keenly assess the drug testing criteria put forth by governing authorities.
Powders and oils are the primary forms through which vitamin K2 would be integrated in foods.
A drastic increase in the consumption of functional foods by the citizens of Australia, China, and India are likely to speed up the demand of vitamin K2 in Asia Pacific over the next five years.
